- call +1-201-465-4211
- email sales@mrinsights.biz
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
Figure Human Rabies Immunoglobulin (IM) is rabies immunoglobulin antibody by the high price of healthy human plasma protein low temperature ethanol separation or other separation methods approved separation and purification, and by virus removal and inactivation treatment is made. Mainly used for rabies or other crazy animal bites, scratches patient's passive immunization.
Scope of the Report:
The classification according to the material of Human Rabies Immunoglobulin (IM) includes ERIG, HRIG, and the proportion of HRIG in 2017is about 86.7%, and the proportion is in increasing trend from 2013 to 2017.
For ERIGs, the dosage is 40 IU per kg body weight subject to a maximum of 3000 IU. For HRIGs, the dosage is 20 IU per kg body weight subject to a maximum of 1500 IU.
Human Rabies Immunoglobulin (IM) is widely used for the Category II Exposure and Category III Exposure, the most proportion of Human Rabies Immunoglobulin (IM) is used for Category III Exposure, and the proportion in 2017 is about 82.6%.
China is the largest sales place, with a sales market share nearly 61.4% in 2017, because of the population. North America enjoys 4.3% market share.
The worldwide market for Human Rabies Immunoglobulin (IM) is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 450 million US$ in 2024, from 290 million US$ in 2019, according to a new study.
This report focuses on the Human Rabies Immunoglobulin (IM) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
CSL Behring
Grifols
Sanofi
Sichuan Yuanda Shuyang
CNBG
Kamada
CBPO
Shuanglin Bio
Weiguang Bio
Shanghai RAAS
Bharat Serum
VINS
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
ERIG
HRIG
Market Segment by Applications, can be divided into
Category II Exposure
Category III Exposure
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Rabies Immunoglobulin (IM) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Rabies Immunoglobulin (IM), with price, sales, revenue and global market share of Human Rabies Immunoglobulin (IM) in 2017 and 2018.
Chapter 3, the Human Rabies Immunoglobulin (IM) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Rabies Immunoglobulin (IM) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Human Rabies Immunoglobulin (IM) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Human Rabies Immunoglobulin (IM) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Human Rabies Immunoglobulin (IM) Introduction
1.2 Market Analysis by Type
1.2.1 ERIG
1.2.2 HRIG
1.3 Market Analysis by Applications
1.3.1 Category II Exposure
1.3.2 Category III Exposure
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 Business Overview
2.1.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 CSL Behring Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Grifols Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sanofi
2.3.1 Business Overview
2.3.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sanofi Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Sichuan Yuanda Shuyang
2.4.1 Business Overview
2.4.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sichuan Yuanda Shuyang Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 CNBG
2.5.1 Business Overview
2.5.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CNBG Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Kamada
2.6.1 Business Overview
2.6.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Kamada Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 CBPO
2.7.1 Business Overview
2.7.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 CBPO Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Shuanglin Bio
2.8.1 Business Overview
2.8.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Shuanglin Bio Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Weiguang Bio
2.9.1 Business Overview
2.9.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Weiguang Bio Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Shanghai RAAS
2.10.1 Business Overview
2.10.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shanghai RAAS Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Bharat Serum
2.11.1 Business Overview
2.11.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bharat Serum Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 VINS
2.12.1 Business Overview
2.12.2 Human Rabies Immunoglobulin (IM) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 VINS Human Rabies Immunoglobulin (IM) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Human Rabies Immunoglobulin (IM) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Human Rabies Immunoglobulin (IM) Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Rabies Immunoglobulin (IM) Manufacturer Market Share in 2018
3.3.2 Top 6 Human Rabies Immunoglobulin (IM) Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Human Rabies Immunoglobulin (IM) Market Analysis by Regions
4.1 Global Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Regions
4.1.1 Global Human Rabies Immunoglobulin (IM) Sales and Market Share by Regions (2014-2019)
4.1.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Regions (2014-2019)
4.2 North America Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
4.3 Europe Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
4.5 South America Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
5 North America Human Rabies Immunoglobulin (IM) by Country
5.1 North America Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Country
5.1.1 North America Human Rabies Immunoglobulin (IM) Sales and Market Share by Country (2014-2019)
5.1.2 North America Human Rabies Immunoglobulin (IM) Revenue and Market Share by Country (2014-2019)
5.2 United States Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
5.3 Canada Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
5.4 Mexico Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
6 Europe Human Rabies Immunoglobulin (IM) by Country
6.1 Europe Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Country
6.1.1 Europe Human Rabies Immunoglobulin (IM) Sales and Market Share by Country (2014-2019)
6.1.2 Europe Human Rabies Immunoglobulin (IM) Revenue and Market Share by Country (2014-2019)
6.2 Germany Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
6.3 UK Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
6.4 France Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
6.5 Russia Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
6.6 Italy Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
7 Asia-Pacific Human Rabies Immunoglobulin (IM) by Country
7.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Human Rabies Immunoglobulin (IM) Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Human Rabies Immunoglobulin (IM) Revenue and Market Share by Country (2014-2019)
7.2 China Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
7.3 Japan Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
7.4 Korea Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
7.5 India Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
8 South America Human Rabies Immunoglobulin (IM) by Country
8.1 South America Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Country
8.1.1 South America Human Rabies Immunoglobulin (IM) Sales and Market Share by Country (2014-2019)
8.1.2 South America Human Rabies Immunoglobulin (IM) Revenue and Market Share by Country (2014-2019)
8.2 Brazil Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
8.3 Argentina Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
8.4 Colombia Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
9 Middle East and Africa Human Rabies Immunoglobulin (IM) by Countries
9.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Human Rabies Immunoglobulin (IM) Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Human Rabies Immunoglobulin (IM) Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
9.3 Turkey Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
9.4 Egypt Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
9.5 Nigeria Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
9.6 South Africa Human Rabies Immunoglobulin (IM) Sales and Growth Rate (2014-2019)
10 Global Human Rabies Immunoglobulin (IM) Market Segment by Type
10.1 Global Human Rabies Immunoglobulin (IM) Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Human Rabies Immunoglobulin (IM) Sales and Market Share by Type (2014-2019)
10.1.2 Global Human Rabies Immunoglobulin (IM) Revenue and Market Share by Type (2014-2019)
10.2 ERIG Sales Growth and Price
10.2.1 Global ERIG Sales Growth (2014-2019)
10.2.2 Global ERIG Price (2014-2019)
10.3 HRIG Sales Growth and Price
10.3.1 Global HRIG Sales Growth (2014-2019)
10.3.2 Global HRIG Price (2014-2019)
11 Global Human Rabies Immunoglobulin (IM) Market Segment by Application
11.1 Global Human Rabies Immunoglobulin (IM) Sales Market Share by Application (2014-2019)
11.2 Category II Exposure Sales Growth (2014-2019)
11.3 Category III Exposure Sales Growth (2014-2019)
12 Human Rabies Immunoglobulin (IM) Market Forecast (2019-2024)
12.1 Global Human Rabies Immunoglobulin (IM) Sales, Revenue and Growth Rate (2019-2024)
12.2 Human Rabies Immunoglobulin (IM) Market Forecast by Regions (2019-2024)
12.2.1 North America Human Rabies Immunoglobulin (IM) Market Forecast (2019-2024)
12.2.2 Europe Human Rabies Immunoglobulin (IM) Market Forecast (2019-2024)
12.2.3 Asia-Pacific Human Rabies Immunoglobulin (IM) Market Forecast (2019-2024)
12.2.4 South America Human Rabies Immunoglobulin (IM) Market Forecast (2019-2024)
12.2.5 Middle East and Africa Human Rabies Immunoglobulin (IM) Market Forecast (2019-2024)
12.3 Human Rabies Immunoglobulin (IM) Market Forecast by Type (2019-2024)
12.3.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Type (2019-2024)
12.3.2 Global Human Rabies Immunoglobulin (IM) Market Share Forecast by Type (2019-2024)
12.4 Human Rabies Immunoglobulin (IM) Market Forecast by Application (2019-2024)
12.4.1 Global Human Rabies Immunoglobulin (IM) Sales Forecast by Application (2019-2024)
12.4.2 Global Human Rabies Immunoglobulin (IM) Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Human Rabies Immunoglobulin (IM) Picture
Table Product Specifications of Human Rabies Immunoglobulin (IM)
Figure Global Sales Market Share of Human Rabies Immunoglob
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
